Sequenom (SQNM +12.2%) shares surge today after the American College of Obstetricians and...

|By:, SA News Editor

Sequenom (SQNM +12.2%) shares surge today after the American College of Obstetricians and Gynecologists Committee on Genetics and the Society for Maternal-Fetal Medicine Publications Committee issue a joint opinion recommending that cell-free fetal DNA testing be offered to patients at increased risk of aneuploidy, and also as a follow-up test for women with a positive first-trimester or second-trimester screening test result.